
Name
PAVe
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for PAVe
Name
Alternate Names
Alanine mustard
Alkeran
CB-3025
DL Sarcolysine
DL-O-Sarcolysin
L-Phenylalanine Mustard
L-Sarcolysin
Melfalan
Phenylalanine Mustard
Sarcolysine
Sarkoklorin
Sarkolizin
WR-19813
Abbreviations
L-PAM
MPL
PAM
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
8806
008806
57199
Primary Site
Histology
None
Remarks
Alkylating antineoplastic agent. FDA approved uses on multiple myeloma and epithelial non-resectable ovarian carcinoma.
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Coding
This drug should be coded
Name
Alternate Names
Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1
Abbreviations
IBZ
MIH
PCB
PCH
PCI
PCZ
Category
Chemotherapy
Subcategory
Nonclassic alkylating agent
NSC Number
077213
77213
Primary Site
Histology
None
Remarks
An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
29060-LE
Alkaban
LE-29060
Velban
Velbe
Velsar
Vinblastine
Vinblastine sulfate
Abbreviations
VBL
VELB
VLB
Category
Chemotherapy
Subcategory
Plant alkaloid
NSC Number
049842
49842
Primary Site
None
Histology
None
Remarks
A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.
Coding
This drug should be coded
